Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development

Clin Oncol (R Coll Radiol). 2000;12(1):16-24. doi: 10.1053/clon.2000.9105.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacokinetics
  • Biological Availability
  • Cisplatin / administration & dosage
  • Cisplatin / pharmacokinetics
  • Clinical Trials as Topic
  • Daunorubicin / administration & dosage
  • Daunorubicin / pharmacokinetics
  • Doxorubicin / administration & dosage
  • Doxorubicin / pharmacokinetics
  • Drug Carriers
  • Humans
  • Liposomes
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Liposomes
  • Doxorubicin
  • Cisplatin
  • Daunorubicin